Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumateperone in bipolar depression
NCT02600494Phase 3Completed
- Sponsor
- Intra-Cellular Therapies
- Start
- Dec 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lumateperone in bipolar disorder (BD), sponsored by Intra-Cellular Therapies. Started Dec 2015; status: completed.
02
Drugs
lumateperone
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02600494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02600494.